Clinical trial
Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter…
NCT00455806 · Technische Universität Dresden, Other · Unknown status
Key facts
| NCT number | NCT00455806 |
|---|---|
| Title | Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection |
| Official title | Randomized, Controlled, Multicenter Phase III Study for the Efficacy and Tolerability of Triple Therapy With Esomeprazole, Moxifloxacin and Amoxicillin for Rescue Therapy of Helicobacter Pylori Infection |
| Acronym | ESAMOX |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Helicobacter Pylori Infection, Chronic Gastritis |
| Intervention type | Drug |
| Interventions | esomeprazole, moxifloxacin, amoxicillin |
| Enrollment | 132 |
| Start date | Jan 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Apr 4, 2007 |
| Last update posted | Apr 4, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: